To verify this hypothesis, the present study firstly investigated the ability of LF to inhibit the progression of T2D to colon cancer upon expoure to high glucose concentrations, both in vitro and in vivo, then confirmed the inhibitory role of the NT5DC3 protein during the progression of the two diseases. The gene discussed is NT5DC3; the disease is colonic neoplasm.